Advertisement
Screener

INFUSYSTEM HOLDINGS, INC (INFU) ROE

InfuSystem Holdings, Inc ROE

Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • InfuSystem Holdings, Inc roe for the quarter ending 2026-06-30 was 14.44%, a 55.30% increase year-over-year.
  • InfuSystem Holdings, Inc roe for the quarter ending 2026-03-31 was 13.47%, a 132.79% increase year-over-year.
  • InfuSystem Holdings, Inc roe for the quarter ending 2025-12-31 was 11.56%, a 183.60% increase year-over-year.
  • InfuSystem Holdings, Inc roe for the quarter ending 2025-09-30 was 9.96%, a 272.52% increase year-over-year.
  • InfuSystem Holdings, Inc roe for fiscal 2025 was 11.56%, a 183.60% increase from fiscal 2024.
  • InfuSystem Holdings, Inc roe for fiscal 2024 was 4.08%, a 144.49% increase from fiscal 2023.
  • InfuSystem Holdings, Inc roe for fiscal 2023 was 1.67%, a 4346.25% increase from fiscal 2022.
  • InfuSystem Holdings, Inc roe for fiscal 2022 was 0.04%, a 98.73% decline from fiscal 2021.
Available history
2009-12-31 to 2026-06-30
Data captured

Historical ROE

DateROENet income 12 monthNet income 3 monthShareholder equity
2026-06-3014.44%$8.54M$3.23M$59.15M
2026-03-3113.47%$7.91M$1.02M$58.75M
2025-12-3111.56%$6.63M$2.04M$57.33M
2025-09-309.96%$5.52M$2.26M$55.47M
2025-06-309.30%$5.07M$2.60M$54.53M
2025-03-315.78%$3.19M-$267.00K$55.15M
2024-12-314.08%$2.35M$933.00K$57.53M
2024-09-302.67%$1.48M$1.81M$55.51M
2024-06-300.68%$366,000.00$717.00K$53.49M
2024-03-310.16%$84,000.00-$1.11M$52.28M
2023-12-311.67%$872,000.00$72.00K$52.3M
2023-09-301.76%$907,000.00$689.00K$51.47M
2023-06-301.32%$661,000.00$435.00K$49.96M
2023-03-310.13%$62,000.00-$324.00K$48.26M
2022-12-310.04%$18,000.00$107.00K$48M
2022-09-300.62%$298,000.00$443.00K$47.81M
2022-06-30-1.28%-$593,000.00-$164.00K$46.5M
2022-03-310.85%$391,000.00-$368.00K$46.05M
2021-12-312.94%$1.42M$387.00K$48.27M
2021-09-3025.19%$11.7M-$448.00K$46.46M
2021-06-3033.76%$15.09M$820.00K$44.7M
2021-03-3142.87%$18.41M$661.00K$42.95M
2020-12-3142.53%$17.33M$10.67M$40.75M
2020-09-3025.41%$7.47M$2.94M$29.39M
2020-06-3021.61%$5.66M$4.14M$26.2M
2020-03-318.64%$1.9M-$418.00K$22.02M
2019-12-316.09%$1.36M$805.00K$22.33M
2019-09-301.29%$281,000.00$1.14M$21.72M
2019-06-30-6.78%-$1.37M$381.00K$20.25M
2019-03-31-11.44%-$2.26M-$960.00K$19.74M
2018-12-31-5.36%-$1.1M-$275.00K$20.44M
2018-09-30-91.30%-$18.81M-$519.00K$20.61M
2018-06-30-62.13%-$18.42M-$505.00K$29.66M
2018-03-31-60.92%-$19.03M$204.00K$31.23M
2017-12-31-66.90%-$20.71M-$17.99M$30.95M
2017-09-30-6.53%-$3.19M-$129.00K$48.75M
2017-06-30-6.16%-$3M-$1.11M$48.7M
2017-03-31-3.51%-$1.74M-$1.48M$49.63M
2016-12-31-0.44%-$222,000.00-$472.00K$50.69M
2016-09-303.48%$1.78M$56.00K$50.98M
2016-06-305.61%$2.86M$153.00K$50.96M
2016-03-316.60%$3.35M$41.00K$50.67M
2015-12-315.54%$2.79M$1.52M$50.32M
2015-09-304.73%$2.3M$1.14M$48.52M
2015-06-304.26%$2.01M$642.00K$47.26M
2015-03-314.88%$2.26M-$519.00K$46.22M
2014-12-317.23%$3.36M$1.04M$46.45M
2014-09-307.03%$3.19M$852.00K$45.28M
2014-06-306.72%$2.98M$886.00K$44.36M
2014-03-315.07%$2.2M$583.00K$43.45M
2013-12-313.91%$1.67M$864.00K$42.72M
2013-09-302.47%$1.03M$649.00K$41.62M
2013-06-301.00%$410,000.00$105.00K$40.81M
2013-03-31-1.29%-$523,000.00$51.00K$40.52M
2012-12-31-3.72%-$1.49M$221.00K$40.01M
2012-09-30-6.29%-$2.47M$33.00K$39.34M
2012-06-30-48.80%-$19.13M-$828.00K$39.2M
2012-03-31-116.82%-$46.19M-$915.00K$39.54M
2011-12-31-113.14%-$45.44M-$764.00K$40.17M
2011-09-30-115.02%-$46.84M-$16.62M$40.72M
2011-06-30-52.56%-$30.04M-$27.89M$57.15M

Annual ROE

DateROENet income 12 monthShareholder equity
2025-12-3111.56%$6.63M$57.33M
2024-12-314.08%$2.35M$57.53M
2023-12-311.67%$872,000.00$52.3M
2022-12-310.04%$18,000.00$48M
2021-12-312.94%$1.42M$48.27M
2020-12-3142.53%$17.33M$40.75M
2019-12-316.09%$1.36M$22.33M
2018-12-31-5.36%-$1.1M$20.44M
2017-12-31-66.90%-$20.71M$30.95M
2016-12-31-0.44%-$222,000.00$50.69M
2015-12-315.53%$2.79M$50.32M
2014-12-317.23%$3.36M$46.45M
2013-12-313.91%$1.67M$42.72M
2012-12-31-3.72%-$1.49M$40.01M
2011-12-31-113.14%-$45.44M$40.17M
2010-12-31-2.18%-$1.85M$85.14M
2009-12-310.95%$774,000.00$81.47M

Similar stocks

Stock NameCountryMarket CapPE Ratio
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
PRO DEX INC (PDEX)United States$0.234B13.64
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Profound Medical Corp. (PROF)$0.206B-7.37